2427 — Guanze Medical Information Industry (Holding) Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Market Cap
HK$289.75m
Enterprise Value
HK$280.26m
Revenue
CNY155.74m

Annual income statement for Guanze Medical Information Industry (Holding) Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	184	211	177	156	156
Cost of Revenue
Gross Profit	61.6	75.7	81	85.4	62.8
Selling / General / Administrative Expenses
Research And Development
Other Operating Expenses
Total Operating Expenses	145	177	146	117	129
Operating Profit	39.8	33.7	31	39.5	27
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	39	33.1	30	38.6	26.3
Provision for Income Taxes
Net Income After Taxes	29	23.1	18.3	27.9	17.4
Minority Interest
Net Income Before Extraordinary Items
Net Income	29	22.9	17.9	27.6	17.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	29	22.9	17.9	27.6	17.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.031	0.031	0.031	0.029	0.018
Dividends per Share